TCTR20210321001
Not yet recruiting
Phase 1
Comparing the Effectiveness of Daily VS Every other day of Oral Astaxanthin on Improvement Skin Elasticity, A Randomized, Double-blind Clinical Trial
ConditionsHealthy women and elasticity
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Healthy women and elasticity
- Sponsor
- one
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Female 2\. age 30\-45 year old 3\. BMI 18\.5\-29\.9 4\. No underlying disease 5\. No menopause condition 6\. Have the intention of participating in the project from start to finish. And able to come and monitor every time in research work 7\. No behavior or the use of oral drugs or injections that affect the absorption of Astaxanthin such as smoking 8\. No history of hypersensitivity to any of the researched supplements such as soybean oil 9\. Not a skin disease such as allergic rash, inflammation, acne in the area to be tested. 10\. Do not change intake of dietary supplements, or not intake drugs that affect skin conditions, such as isotretionin, tranexamic acid, during the test. 11\. The ablative, semi\-ablative laser was not performed 3 months prior to the test. 12\. Did not do HIFU for 6 months prior to the test. 13\. Ulthera thermage was not performed 12 months prior to the test. 14\. Botulinum toxin has not been injected at the site to be tested for 6 months prior to the test. 15\. Do not inject fillers or stem cells in the area to be tested within 1 year before testing. 16\. Not during pregnancy or breastfeeding.
Exclusion Criteria
- •1\. Get pregnant during the test 2\. Forget to take supplements for more than two consecutive days or more than four days per 2 weeks 3\. There have been botulinum toxin, filler injections or laser during testing. 4\. Use new creams during the experiment or stop using the old product. 5\. There have been changes in the behavior of taking vitamins or other dietary supplements, such as eat more or stop eating things you eat regularly during the test. 6\. There is an increase in stress during the test. For example, moving home, having trouble sleeping, etc. 7\. Volunteers withdraw from the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of the effectiveness and safety of daily versus alternate day dapagliflozin therapy among patients with type 2 diabetes mellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsHealth Condition 2: E119- Type 2 diabetes mellitus without complicationsCTRI/2021/12/038868Department of Science Technology Renewable Energy Chandigarh Administration Chandigarh
Terminated
Phase 3
Daily Tenderwet dressings vs QID normal Saline compress as wound debridement agentsACTRN12605000180617Fremantle Hospital & Health Service60
Completed
Phase 2
Comparison of the effect of single and twice daily administration of ranitidine in relief of morning abdominal pain and nausea in childreabdominal pain and nausea.Unspecified abdominal painIRCT20171211037830N2Deputy of Research of Golestan University of Medical Sciences150
Not yet recruiting
Phase 4
Glargine once versus twice dailyCTRI/2023/10/059275surbhi bharti
Completed
Phase 4
Efficacy of once daily versus divided daily administration of low daily dosage (15 mg/day) of methimazole in the induction of euthyroidism in Graves' hyperthyroidism: A randomized controlled studyGraves’ hyperthyroidismGraves’ hyperthyroidism,once daily methimazole administration,induction of euthyroidismTCTR20170529001one55